Now showing items 1-2 of 2

    • Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients 

      CIKRIKCIOGLU, M. A.; OZDEMIR, A. A.; SEKIN, Y.; YALCIN, BURAK; ALTAY, M.; GUNDOGDU, A.; Erkal, S. N.; Kazancioglu, RÜMEYZA; ERKOC, R. (2015-09-01)
      Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.
    • Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease 

      Karatoprak, CUMALİ; CIKRIKCIOGLU, M. A.; Cakirca, MUSTAFA; Kiskac, MUHARREM; Zorlu, MEHMET; Cetin, GÜVEN; YILDIZ, KEMALETTİN; ERKOC, R.; ALAY, M.; Erkal, S.; Erkal, S. N.; DOGAN, S.; Kazancioglu, RÜMEYZA (2013-09-01)
      Aim: To search whether calcium channel blockers (CCBs) are associated with lower hemoglobin levels in chronic kidney disease (CKD) patients who are not on renal replacement therapy (RRT), vitamin D and anti-anemic ...